207229f284b91ec0bd2eaa856fe639d7786fe8e9 max Mon Apr 27 12:26:51 2020 -0700 adding T cell epitopes track, refs #25458 diff --git src/hg/makeDb/trackDb/targets.html src/hg/makeDb/trackDb/targets.html new file mode 100644 index 0000000..1ed3a9f --- /dev/null +++ src/hg/makeDb/trackDb/targets.html @@ -0,0 +1,28 @@ +<H2>Description</H2> +<P> +<p>This track shows data from Braun et al, 2020,<a target=_blank href = "https://www.medrxiv.org/content/10.1101/2020.04.17.20061440v1.full.pdf+html">"Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors"</a> +<p>The authors stimulated PBMCs with two sets (M1 and M2) of overlapping SARS-CoV peptide pools. +Importantly these are SARS-Cov peptides that have experimental support as putative MHC-II epitopes for SARS-CoV, but note they do not all 100% match SARS-Cov-2 sequence. +Using these peptide sets, the authors "demonstrate the presence of S-reactive CD4+ 52 T cells in 83% of COVID-19 patients, 53 as well as in 34% of SARS-CoV-2 seronegative healthy donors (HD), albeit at lower frequencies." + +<h2>Display Conventions and Configuration</h2> +<p> +Two tracks are available: +</p> +<ul> +<li>M1_peptides: The more N-terminal peptide library +<li>M2 peptides: The more C-terminal peptide library +</ul> + +<p> The annotated interval represents the alignment of the peptide to the viral +genome. The sequence displayed in the name is SARS-CoV peptide sequence (which +is the actual sequence which was used in the paper, but not necessarily +identical to the SARS-CoV-2 peptide).</p> + +<h2>Methods</h2> +<p>Table S1 contains the peptide sequences (SARS-CoV sequence) used. This table was downloaded and tblastn was used to align the identified the SARS-CoV peptides to the SARS-CoV-2 genome. +<p>A small number of peptides were not found or reported erroneous hits, in which the coordinates were identified by manually blat-ing the SARS-CoV-2 sequence from the alignments reported in Fig S1. +<p> + +<h2>References</h2> +Braun et al, 2020<a target=_blank href = "https://www.medrxiv.org/content/10.1101/2020.04.17.20061440v1.full.pdf+html">"Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors"</a>